missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Recombinant Human LIF Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

POA

Specifications

Accession Number P15018
For Use With (Application) Bioactivity
Gene ID (Entrez) 3976
Molecular Weight (g/mol) M.W. (Observed): 19 kDa, reducing conditions; M.W. (theoretical): 19.6 kDa
Name LIF
View More Specs

Description

Description

Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is 0.02-0.12 ng/mL.
Specifications

Specifications

P15018
3976
LIF
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
CDF, D factor, DIA, differentiation inhibitory activity, differentiation stimulating factor, Differentiation-stimulating factor, Emfilermin, HILDA, HILDAcholinergic differentiation factor, leukemia inhibitory factor, leukemia inhibitory factor (cholinergic differentiation factor), Melanoma-derived LPL inhibitor, MLPLI
Unconjugated
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
Bioactivity
M.W. (Observed): 19 kDa, reducing conditions; M.W. (theoretical): 19.6 kDa
E. coli-derived human LIF protein Pro24-Phe202
<0.01 EU / 1 μg of the protein by the LAL method.
LIF
Recombinant
LIF
Videos
SDS
Documents

Documents

Product Certifications